Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Acta Ortopedica Brasileira
|
March 22, 2016
EPIDEMIOLOGY AND TREATMENT OF MONTEGGIA LESION IN ADULTS: SERIES OF 44 CASES
Roberto Suarez, Antonio Barquet, Rodrigo Fresco
Tumori
|
August 12, 2003
Synchronous presentation of an Askin tumor and a plasmacytoma in an adult patient
Rodrigo Fresco, Lyber Saldombide, Liliana Suárez
Epidemiology (Cambridge, Mass.)
|
May 18, 2018
The Authors Respond
Gonzalo Spera, Rodrigo Fresco, Helena Fung, et al.
The Oncologist
|
May 31, 2015
Imaging Radiation Doses and Associated Risks and Benefits in Subjects Participating in Breast Cancer Clinical Trials
Rodrigo Fresco, Gonzalo Spera, Carlos Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Reply to H.J. Lee et al
John R Mackey, Vincent Houé, Francois Thireau, et al.
Clinical Breast Cancer
|
March 10, 2019
Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy
Carlos Meyer, Pablo Millán, Valeria González, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
Final Survival Analysis of ROSE/TRIO-012
John R Mackey, Nicole McCarthy, Karen A Gelmon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2025
Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial
Peter A Fasching, Dennis Slamon, Zbigniew Nowecki, et al.
The Lancet. Oncology
|
November 28, 2017
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
Sara A Hurvitz, Miguel Martin, W Fraser Symmans, et al.
JAMA Oncology
|
September 25, 2025
Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial
Peter A Fasching, Daniil Stroyakovskiy, Denise A Yardley, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Acta Ortopedica Brasileira
|
March 22, 2016
EPIDEMIOLOGY AND TREATMENT OF MONTEGGIA LESION IN ADULTS: SERIES OF 44 CASES
Roberto Suarez, Antonio Barquet, Rodrigo Fresco
Tumori
|
August 12, 2003
Synchronous presentation of an Askin tumor and a plasmacytoma in an adult patient
Rodrigo Fresco, Lyber Saldombide, Liliana Suárez
Epidemiology (Cambridge, Mass.)
|
May 18, 2018
The Authors Respond
Gonzalo Spera, Rodrigo Fresco, Helena Fung, et al.
The Oncologist
|
May 31, 2015
Imaging Radiation Doses and Associated Risks and Benefits in Subjects Participating in Breast Cancer Clinical Trials
Rodrigo Fresco, Gonzalo Spera, Carlos Meyer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 22, 2015
Reply to H.J. Lee et al
John R Mackey, Vincent Houé, Francois Thireau, et al.
Clinical Breast Cancer
|
March 10, 2019
Intensive Imaging Surveillance of Survivors of Breast Cancer May Increase Risk of Radiation-induced Malignancy
Carlos Meyer, Pablo Millán, Valeria González, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 3, 2016
Final Survival Analysis of ROSE/TRIO-012
John R Mackey, Nicole McCarthy, Karen A Gelmon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 28, 2025
Health-Related Quality of Life in Patients with HR+/HER2- Early Breast Cancer Treated with Ribociclib Plus a Nonsteroidal Aromatase Inhibitor: Results from the NATALEE Trial
Peter A Fasching, Dennis Slamon, Zbigniew Nowecki, et al.
The Lancet. Oncology
|
November 28, 2017
Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial
Sara A Hurvitz, Miguel Martin, W Fraser Symmans, et al.
JAMA Oncology
|
September 25, 2025
Ribociclib Plus Endocrine Therapy in Hormone Receptor-Positive/ERBB2-Negative Early Breast Cancer: 4-Year Outcomes From the NATALEE Randomized Clinical Trial
Peter A Fasching, Daniil Stroyakovskiy, Denise A Yardley, et al.
Page
of 2